MeSH term
Frequency | Condition_Probility | *Antigens, Protozoan | 2 | 10.0 |
Flow Cytometry | 2 | 0.0 |
Humans | 35 | 0.0 |
*Protozoan Proteins | 2 | 5.0 |
Genetic Markers | 8 | 0.0 |
HLA Antigens/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Female | 20 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Male | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Alleles | 7 | 0.0 |
Genotype | 4 | 0.0 |
ABO Blood-Group System/genetics | 4 | 9.0 |
Adult | 4 | 0.0 |
Blood Group Antigens/*genetics | 7 | 6.0 |
Duffy Blood-Group System/genetics | 4 | 50.0 |
Phenotype | 5 | 0.0 |
Rh-Hr Blood-Group System/genetics | 3 | 10.0 |
Animals | 2 | 0.0 |
Polymorphism, Genetic | 7 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Emigration and Immigration | 2 | 4.0 |
Gene Frequency/*genetics | 2 | 1.0 |
Atlantic Islands | 2 | 25.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Gene Frequency | 4 | 0.0 |
Infant | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Isoantigens/genetics | 2 | 10.0 |
Lod Score | 5 | 0.0 |
Genes, Dominant | 4 | 0.0 |
Linkage (Genetics) | 6 | 0.0 |
Pedigree | 10 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics | 4 | 2.0 |
*Chromosomes, Human, Pair 1 | 4 | 0.0 |
*Linkage (Genetics) | 13 | 1.0 |
Antithrombin III/genetics | 2 | 15.0 |
Muscular Atrophy, Spinal/*genetics | 3 | 4.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, 1-3 | 4 | 7.0 |
Recombination, Genetic | 4 | 0.0 |
Sex Factors | 2 | 0.0 |
Africa/ethnology | 2 | 4.0 |
*Blood Group Antigens | 2 | 3.0 |